MedTrace Logo

The Endocannabinoid System in Human Gestational Tissues in Labor

NCT03752021 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-08-15

No results posted yet for this study

Summary

The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.

Conditions

  • Labor

Interventions

PROCEDURE

Myometrial Sampling

A myometrial sample will be obtained at the time of cesarean delivery. Sample will be obtained from the superior edge of the existing lower uterine segment incision and will be 2 inches in length and 0.5 inches in width. The uterine incision will be repaired in a standard two-layer closure. If a classical cesarean (vertical) uterine incision is deemed necessary and is performed by the surgical team, a sample of the same size will be taken parallel to the incision at the existing edge. The classical uterine incision will be closed utilizing the standard layered technique. Placenta and gestational membrane tissue will be obtained after placental delivery. The entire placenta and attached gestational membranes will be collected if not being sent for pathologic review

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Melissa L Kozakiewicz, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-25
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03752021 on ClinicalTrials.gov